摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-methoxycarbonyl-5-oxo-2,3,6,7-tetrahydro-1H-indolizine-7-carboxylic acid | 1604038-25-6

中文名称
——
中文别名
——
英文名称
8-methoxycarbonyl-5-oxo-2,3,6,7-tetrahydro-1H-indolizine-7-carboxylic acid
英文别名
——
8-methoxycarbonyl-5-oxo-2,3,6,7-tetrahydro-1H-indolizine-7-carboxylic acid化学式
CAS
1604038-25-6
化学式
C11H13NO5
mdl
——
分子量
239.228
InChiKey
NHCXIOREOXMBIG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    83.9
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    8-methoxycarbonyl-5-oxo-2,3,6,7-tetrahydro-1H-indolizine-7-carboxylic acid溶剂黄146 作用下, 反应 24.0h, 以70%的产率得到甲基5-氧代-1,2,3,5-四氢-8-吲嗪羧酸酯
    参考文献:
    名称:
    Design, synthesis and cytotoxicity of the antitumor agent 1-azabicycles for chemoresistant glioblastoma cells
    摘要:
    以五元至七元杂环烯酮作为不同的暧昧亲电体,通过正式的氮杂环合-[3 + 2]和氮杂环合-[3 + 3]环加成反应,制备了 12 种多功能吡咯烷酮、吲哚利嗪酮和吡咯并氮杂卓酮。通过对人类多形性胶质母细胞瘤(GBM)细胞系(GL-15、U251)、鼠胶质瘤细胞系(C6)和正常胶质细胞进行初步筛选,研究了这些生物碱类化合物的抗肿瘤活性。在测试的化合物中,新的吡咯并[1,2a]氮杂环庚酮[(3-氧代-1,2-二苯基-6,7,8,9-四氢-3H-吡咯并[1,2a]氮杂环庚-9a(5H)-基)乙酸乙酯]或(化合物-13)对 GBM-替莫唑胺耐药细胞具有选择性细胞毒性作用。化合物-13 具有剂量依赖性的细胞毒性活性,在细胞周期的前 24 h 促进细胞停滞在 G0/G1 期。观察到的凋亡效应与时间有关。化合物-13 还具有抗迁移作用。此外,来自大鼠大脑的健康混合胶质细胞培养物在暴露于化合物-13 后没有表现出细胞毒性效应。因此,本研究为将化合物-13 用作胶质瘤细胞治疗的新型抗肿瘤支架候选物铺平了道路。
    DOI:
    10.1007/s10637-019-00877-2
  • 作为产物:
    描述:
    马来酸酐methyl α-(tetrahydro-2-pyrrolidinylidene)acetate二氯甲烷 为溶剂, 反应 0.5h, 以85%的产率得到8-methoxycarbonyl-5-oxo-2,3,6,7-tetrahydro-1H-indolizine-7-carboxylic acid
    参考文献:
    名称:
    Formal aza-[3+3] versus aza-[3+2] cycloadditions of heterocyclic enaminones with maleic anhydride and maleimides: skeletally diverse synthesis of pyrrolizidinones, indolizidinones, and pyrroloazepinones
    摘要:
    The domino aza-annulation of cyclic enaminones with maleic anhydride and maleimides was investigated, and selectively one-step skeletally diverse synthesis of each alkaloid-like pyrrolizidinone, indolizidinone, and pyrrolo[1,2-a]azepinone was developed, switching between aza-[3+3] and aza-[3+2] modes of formal cycloaddition reactions. For the synthesis of pyrroloazepinones, seven-membered enaminone and maleic anhydride or maleimides are efficient, via the [3+2] mode. To access indolizidinones, five or six-membered enaminones are the choice, and both [3+2] and [3+3] modes were viable exclusively with maleic anhydride. Pyrrolizidinone can be selectively synthesized in good yield through the [3+2] mode, only with five-membered enaminone and N-(4-NO2Ph)maleimide, under catalysis by PTSA. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2013.10.071
点击查看最新优质反应信息

文献信息

  • Formal aza-[3+3] versus aza-[3+2] cycloadditions of heterocyclic enaminones with maleic anhydride and maleimides: skeletally diverse synthesis of pyrrolizidinones, indolizidinones, and pyrroloazepinones
    作者:Silvio Cunha、Airam Oliveira Santos、José Tiago Menezes Correia、José Ricardo Sabino
    DOI:10.1016/j.tet.2013.10.071
    日期:2014.5
    The domino aza-annulation of cyclic enaminones with maleic anhydride and maleimides was investigated, and selectively one-step skeletally diverse synthesis of each alkaloid-like pyrrolizidinone, indolizidinone, and pyrrolo[1,2-a]azepinone was developed, switching between aza-[3+3] and aza-[3+2] modes of formal cycloaddition reactions. For the synthesis of pyrroloazepinones, seven-membered enaminone and maleic anhydride or maleimides are efficient, via the [3+2] mode. To access indolizidinones, five or six-membered enaminones are the choice, and both [3+2] and [3+3] modes were viable exclusively with maleic anhydride. Pyrrolizidinone can be selectively synthesized in good yield through the [3+2] mode, only with five-membered enaminone and N-(4-NO2Ph)maleimide, under catalysis by PTSA. (C) 2013 Elsevier Ltd. All rights reserved.
  • Design, synthesis and cytotoxicity of the antitumor agent 1-azabicycles for chemoresistant glioblastoma cells
    作者:Mona Oliveira、Lourenço Luis Botelho de Santana、José Claudio Serafim、Airam Oliveira Santos、Michelle Pereira Quintino、José Tiago Menezes Correia、Fabiano Damasceno、José Ricardo Sabino、Thiago Rubens Cardim Pires、Paulo Lucas Cerqueira Coelho、Giselle Pinto de Faria Lopes、Henning Ulrich、Silvia Lima Costa、Silvio Cunha
    DOI:10.1007/s10637-019-00877-2
    日期:2020.10
    Twelve multi-functional pyrrolizidinones, indolizidinones and pyrroliazepinones were prepared from formal aza-[3 + 2] and aza-[3 + 3] cycloadditions of five- to seven-membered heterocyclic enaminones as diverse ambident electrophiles. The antitumor activity of these alkaloid-like compounds was investigated through an initial screening performed on human glioblastoma multiform (GBM) cell lines (GL-15, U251), on murine glioma cells line (C6) and on normal glial cells. Of the compounds tested, the new pyrrolo[1,2a]azepinone, [ethyl (3-oxo-1,2-diphenyl-6,7,8,9-tetrahydro-3H-pyrrolo[1,2a]azepin-9a(5H)-yl)acetate] or (Compound-13) exhibited selective cytotoxic effects on GBM-temozolomide resistant cells. Compound-13 exerted dose-dependent cytotoxic activity by promoting arrest of cells in the G0/G1 phase of the cell cycle in the first 24 h. The apoptotic effect observed was in a time-dependent manner. Anti-migratory effect promoted by the treatment with compound-13 was also observed. Moreover, healthy mixed glial cell cultures from rat brain exhibited no cytotoxicity effect upon exposure to compound-13. Thus, the present study paves the way for the use of compound-13 as novel antitumor scaffold candidate for glioma cell therapy.
    以五元至七元杂环烯酮作为不同的暧昧亲电体,通过正式的氮杂环合-[3 + 2]和氮杂环合-[3 + 3]环加成反应,制备了 12 种多功能吡咯烷酮、吲哚利嗪酮和吡咯并氮杂卓酮。通过对人类多形性胶质母细胞瘤(GBM)细胞系(GL-15、U251)、鼠胶质瘤细胞系(C6)和正常胶质细胞进行初步筛选,研究了这些生物碱类化合物的抗肿瘤活性。在测试的化合物中,新的吡咯并[1,2a]氮杂环庚酮[(3-氧代-1,2-二苯基-6,7,8,9-四氢-3H-吡咯并[1,2a]氮杂环庚-9a(5H)-基)乙酸乙酯]或(化合物-13)对 GBM-替莫唑胺耐药细胞具有选择性细胞毒性作用。化合物-13 具有剂量依赖性的细胞毒性活性,在细胞周期的前 24 h 促进细胞停滞在 G0/G1 期。观察到的凋亡效应与时间有关。化合物-13 还具有抗迁移作用。此外,来自大鼠大脑的健康混合胶质细胞培养物在暴露于化合物-13 后没有表现出细胞毒性效应。因此,本研究为将化合物-13 用作胶质瘤细胞治疗的新型抗肿瘤支架候选物铺平了道路。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-